Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Verrièle L

Collect these papers and discover other ones on Labmeeting. Learn more.

Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT(6) receptors: A comparative study of coupling to Galphas.

+ cite this

+ View Abstract

Dupuis DS, la Cour CM, Chaput C, Verrièle L, Lavielle G, and Millan MJ

European journal of pharmacology 588(2-3):170, 2008 Jul 7 - Who cited this? | PubMed ID: 18511034 | Fulltext

Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.

+ cite this

+ View Abstract

Newman-Tancredi A, Cussac D, Quentric Y, Touzard M, Verrièle L, Carpentier N, and Millan MJ

The Journal of pharmacology and experimental therapeutics 303(2):815-22, 2002 Nov - Who cited this? | PubMed ID: 12388668 | Fulltext

Efficacy of antipsychotic agents at human 5-HT(1A) receptors determined by [3H]WAY100,635 binding affinity ratios: relationship to efficacy for G-protein activation.

+ cite this

+ View Abstract

Newman-Tancredi A, Verrièle L, Touzard M, and Millan MJ

European journal of pharmacology 428(2):177-84, 2001 Oct 5 - Who cited this? | PubMed ID: 11675034 | Fulltext

Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.

+ cite this

+ View Abstract

Newman-Tancredi A, Verrièle L, and Millan MJ

British journal of pharmacology 132(2):518-24, 2001 Jan - Who cited this? | PubMed ID: 11159702 | Fulltext

Inverse agonism and constitutive activity as functional correlates of serotonin h5-HT(1B) receptor/G-protein stoichiometry.

+ cite this

+ View Abstract

Newman-Tancredi A, Audinot V, Moreira C, Verrièle L, and Millan MJ

Molecular pharmacology 58(5):1042-9, 2000 Nov - Who cited this? | PubMed ID: 11040052 | Fulltext

The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.

+ cite this

+ View Abstract

Newman-Tancredi A, Rivet J, Chaput C, Touzard M, Verrièle L, and Millan MJ

European journal of pharmacology 384(2-3):111-21, 1999 Nov 19 - Who cited this? | PubMed ID: 10611431 | Fulltext

Parallel evaluation of 5-HT1A receptor localization and functionality: autoradiographic studies with [35S]-GTP gamma S and the novel, selective radioligand, [3H]-S 15535.

+ cite this

Newman-Tancredi A, Chaput C, Touzard M, Verrièle L, and Millan MJ

Annals of the New York Academy of Sciences 861:263-4, 1998 Dec 15 - Who cited this? | PubMed ID: 9928280 | Fulltext

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study.

+ cite this

+ View Abstract

Newman-Tancredi A, Gavaudan S, Conte C, Chaput C, Touzard M, Verrièle L, Audinot V, and Millan MJ

European journal of pharmacology 355(2-3):245-56, 1998 Aug 21 - Who cited this? | PubMed ID: 9760039 | Fulltext

Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.

+ cite this

+ View Abstract

Newman-Tancredi A, Nicolas JP, Audinot V, Gavaudan S, Verrièle L, Touzard M, Chaput C, Richard N, and Millan MJ

Naunyn-Schmiedeberg's archives of pharmacology 358(2):197-206, 1998 Aug - Who cited this? | PubMed ID: 9750005 | Fulltext

Agonist and antagonist actions of (-)pindolol at recombinant, human serotonin1A (5-HT1A) receptors.

+ cite this

+ View Abstract

Newman-Tancredi A, Chaput C, Gavaudan S, Verrièle L, and Millan MJ

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 18(5):395-8, 1998 May - Who cited this? | PubMed ID: 9536453 | Fulltext

Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.

+ cite this

+ View Abstract

Newman-Tancredi A, Verrièle L, Chaput C, and Millan MJ

Naunyn-Schmiedeberg's archives of pharmacology 357(3):205-17, 1998 Mar - Who cited this? | PubMed ID: 9550290 | Fulltext

[35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.

+ cite this

+ View Abstract

Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, and Millan MJ

The Journal of pharmacology and experimental therapeutics 282(1):181-91, 1997 Jul - Who cited this? | PubMed ID: 9223553 | Fulltext

Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy.

+ cite this

+ View Abstract

Newman-Tancredi A, Conte C, Chaput C, Verrièle L, Audinot-Bouchez V, Lochon S, Lavielle G, and Millan MJ

Naunyn-Schmiedeberg's archives of pharmacology 355(6):682-8, 1997 Jun - Who cited this? | PubMed ID: 9205951 | Fulltext

Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry.

+ cite this

+ View Abstract

Newman-Tancredi A, Conte C, Chaput C, Verrièle L, and Millan MJ

Neuropharmacology 36(4-5):451-9, 1997 - Who cited this? | PubMed ID: 9225269 | Fulltext

S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.

+ cite this

+ View Abstract

Newman-Tancredi A, Chaput C, Verrièle L, and Millan MJ

European journal of pharmacology 307(1):107-11, 1996 Jun 20 - Who cited this? | PubMed ID: 8831111 | Fulltext

Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors.

+ cite this

+ View Abstract

Newman-Tancredi A, Chaput C, Verriele L, and Millan MJ

Neuropharmacology 35(1):119-21, 1996 Jan - Who cited this? | PubMed ID: 8684591 | Fulltext

Down-regulation of rat beta-adrenoceptors by clenbuterol or desipramine does not require chronic treatment: [3H] CGP-12177 binding reveals rapid (24 hour) modulation.

+ cite this

+ View Abstract

Newman-Tancredi A, Verrièle L, Chaput C, and Millan MJ

Brain research bulletin 41(2):93-6, 1996 - Who cited this? | PubMed ID: 8879672 | Fulltext

Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics.

+ cite this

+ View Abstract

Canton H, Verrièle L, and Millan MJ

Neuroscience letters 181(1-2):65-8, 1994 Nov 7 - Who cited this? | PubMed ID: 7898773 | Fulltext

S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.

+ cite this

+ View Abstract

Millan MJ, Rivet JM, Canton H, Lejeune F, Bervoets K, Brocco M, Gobert A, Lefebvre de Ladonchamps B, Le Marouille-Girardon S, and Verriele L

The Journal of pharmacology and experimental therapeutics 262(2):451-63, 1992 Aug - Who cited this? | PubMed ID: 1323650 | Fulltext

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites.

+ cite this

+ View Abstract

Canton H, Verrièle L, and Colpaert FC

European journal of pharmacology 191(1):93-6, 1990 Nov 20 - Who cited this? | PubMed ID: 1982659 | Fulltext

Search Google Scholar for Verrièle L

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!